SEC Form 4/A · accession 0001209191-18-027217
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Steven St Peter
Officer — PRESIDENT AND CEO · Director
Period of report
Apr 30, 2018
Accepted (ET)
May 1, 2018 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Apr 30, 2018 | S | 11,513 | $5.0015 | D | 660,746 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4/A has been filed solely to change the code reported in Column 4 of Table I of the Reporting Person's Form 4 filed on April 30, 2018, which had inadvertently noted an "A" instead of "D" to reflect a disposition of the Issuer's common stock, due to an administrative error.
- F2The sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on September 13, 2017.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.99 to $5.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.